Skip to main content

Nasdaq IPOs

Oncology biotech Immuneering files for a $100 million IPO

5 years 2 months ago
Immuneering, a preclinical biotech targeting signaling pathways to treat cancer and neurological diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Immuneering's oncology programs target mutations of the MAPK and mTOR pathways, whic
Renaissance Capital

Gene therapy biotech Omega Therapeutics files for a $100 million IPO

5 years 2 months ago
Omega Therapeutics, a preclinical biotech developing gene therapies for cancer and other diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Omega Therapeutics aims to use its proprietary OMEGA Epigenomic Programming platform to pion
Renaissance Capital
Checked
6 minutes 59 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed